The Irish Medicines Board (now known as the HPRA) published its Drug Safety Newsletter (62nd edition) on Friday 20th June 2014. However due to technical issues, some subscribers may not have received an alert. To ensure all subscribers have, the HPRA are re-publishing the newsletter today. Please accept our apologies for any inconvenience caused.
Topics covered in this edition of the newsletter include:
- Reminder of ivabradine (Procoralan) conditions for use to avoid potentially dangerous bradycardia
- HIQA-New Guidelines for Healthcare Professionals aimed at reducing medication errors
- IMB Name Change
- Direct Healthcare Professional Communications published on the IMB website since the last Drug Safety Newsletter